NCT05436834 A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age Status COMPLETED Phase PHASE3
NCT05435027 Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) Status COMPLETED Phase PHASE1
NCT05433181 ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19) Status WITHDRAWN Phase PHASE1/PHASE2
NCT05428592 Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad Status UNKNOWN Phase PHASE3
NCT05403346 Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™) Status TERMINATED Phase N/A
NCT05375838 A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old Status COMPLETED Phase PHASE1/PHASE2
NCT05367908 A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind Status COMPLETED Phase N/A
NCT05366322 A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults Status COMPLETED Phase N/A
NCT05354089 A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years. Status UNKNOWN Phase PHASE1
NCT05354063 A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults. Status UNKNOWN Phase PHASE1
NCT05352867 Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People Status COMPLETED Phase PHASE2
NCT05281692 Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) Status COMPLETED Phase N/A
NCT05281601 AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics Status COMPLETED Phase PHASE1
NCT05280158 High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients Status TERMINATED Phase PHASE1/PHASE2
NCT05272605 Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults Status COMPLETED Phase PHASE1
NCT05260437 Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants Status COMPLETED Phase PHASE1
NCT05249829 A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT05233826 Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19 Status COMPLETED Phase PHASE1